Taiwantrade to Showcase Award-Winning Food Innovations at Food Taipei 2025
TAIPEI, June 17, 2025 /PRNewswire/ -- Taiwantrade.com – the go-to B2B sourcing platform for premium Taiwanese products, is thrilled to announce its participation in Food Taipei 2025. The event will take place from June 25 to June 28 at booth Q1230, Hall 2, Taipei Nangang Exhibition Center.
At the Taiwantrade booth, visitors will experience a curated selection of Taiwan's finest food and beverage innovations. Highlights include live demonstrations of KLUB's Teapresso machine, offering freshly brewed tea on-site for guests to enjoy. Visitors will also get the opportunity to taste award-winning food products, including:
Taro balls by Taro Yuan (iTQi 1 star 2023)
The Caramel Almond Boat by ISABELLE (TAIWAN) CO., LTD. (iTQi 1 star 2022)
Instant Popping Boba Drink by puly (Gold award by Monde Selection 2025 and iTQi 2 stars 2022)
Taiwantrade.com is also extending the exhibition experience online through its dedicated Food Industry Pavilion — now live at: https://foodpavilion.taiwantrade.com/home.html The online pavilion features over 30,000 high-quality food-related products from over 4,000 Taiwanese suppliers, including snacks, beverages, frozen foods, Halal-certified items, vegetarian products, and food machinery. Global buyers can easily browse and source from Taiwan's top exporters — all in one place.
About TaiwantradeTaiwantrade.com is Taiwan's largest B2B sourcing platform, offering free access to over 660,000 products from more than 72,000 verified Taiwanese suppliers. The platform connects global buyers with reliable manufacturers. To help buyers connect with suppliers, Taiwantrade.com offers a range of customized sourcing services, including the "Meet Supplier Online" program. For more details, visit www.taiwantrade.com.
View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/taiwantrade-to-showcase-award-winning-food-innovations-at-food-taipei-2025-302482653.html
SOURCE Taiwantrade.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
an hour ago
- Bloomberg
Starbucks and Others Rethink Recipe for Success in China
Hi, it's Dong Cao and Manuel Baigorri in Hong Kong, looking at how some big-name international brands are reassessing their approach to business in China. Also today, Eli Lilly's latest move to build its drug pipeline in heart disease. Today's top stories Durian pizzas, Peking duck-style wraps and Oreo Spam burgers—these have all, at one time or another, been available in China as big Western brands such as Pizza Hut, KFC and McDonald's have tailored offerings to appeal to local consumers.
Axios
2 hours ago
- Axios
It's a bad time to launch first-time funds, but that isn't stopping investors
Conventional wisdom is that now is a terrible time for private market investors to launch first-time funds. But that isn't stopping a slew of folks from trying. The big picture: Limited partners are seeing a wave of general partners spinouts, and many expect that the trend will outpace industry consolidation, according to a recent Coller Capital survey. One major reason, they say, is that firms have done a lousy job nurturing homegrown talent. Coller's questionnaire didn't go a level deeper, but it's not too hard to read "tilted fund economics" in that response. Everyone inside a firm knows who brings in the home run deals, and if that rainmaker doesn't get compensated like one. By the numbers: 38% of LP respondents said they expect the number of new managers to increase over the next three to five years, compared to just 33% who say they expect it to decrease. The "increase" cohort was particularly strong among Asia-Pacific respondents (64%). Coller also found that 36% of LPs report the number of spinout funds within their portfolio has increased within the past few years, while only 3% said it's decreased. The majority said it's remained flat. Zoom out: Raising a first-time fund is never easy, and many believe the process has become even more challenging as LPs have sought to shrink their manager rosters — preferring to plug larger amounts into multi-strategy firms. Plus the VC/PE distribution drought that's reduced the amount of available LP capital. On the other hand, LPs also worry that too much mega-fund exposure won't allow them to beat industry benchmarks — which means many are willing to bet on a few emerging managers to provide alpha. What they're saying: "It's like the old phrase: people hate Congress but love their congressperson," a veteran LP tells me. "A lot of people are super risk averse (and liquidity crunched) right now, making emerging funds a challenge to raise, but known quantities de-risk the decision for those who are able to put out capital."
Bloomberg
2 hours ago
- Bloomberg
Blistering Rally in Herbal Medicine Stock Mints $26 Billion Fortune
A blistering rally in a tiny, money-losing traditional Chinese medicine company's stock has vaulted its founder's net worth to among the world's 100 largest fortunes. The firm, Hong Kong-based Regencell Bioscience Holding Ltd., was for all intents and purposes trading as a microcap stock on the Nasdaq just eight weeks ago. But its shares have since exploded, gaining more than 46,000% this year as of Monday's close. The move has boosted the value of Chief Executive Officer Yat-Gai Au's 86% stake to $25.6 billion, according to the Bloomberg Billionaires Index, making Au's paper wealth greater than rich-list stalwarts such as Jerry Jones and Masayoshi Son.
